Literature DB >> 15190789

[In vitro and in vivo study on proliferation of adnoid cystic carcinoma cell lines after nm23-h1. Introduction].

Wen Li1, Yu-ming Wen, Li-hong Wang, Zhan Yang, Rui-lin Zhang.   

Abstract

OBJECTIVE: To study the effect of nm23-h1 transfection on proliferation characteristics of adnoid carcinoma cell lines in vitro and in vivo.
METHODS: In vitro ACC-M cell lines were incubated after putative anti-metastatic gene nm23-h1 was introduced into the cells with the help of G418 selective incubation base. The ACC-M cells were transplanted into 10 BALB/C nude mices subcutaneously and non-transfected cell lines were taken as control. Immunohisto chemistry and Ki67 antibody were employed to study the proliferation character of cell crawling pieces and paraffin-bedded slice, meanwhile, the solid tumor of both groups were prepared for flow cytometry(FCM).
RESULTS: Transfected cells grew slower than non-transfected cells and this trend became more obvious as passages passed on. In vitro the expression of Ki67 of transfected cells was little stronger than non-transfected cells, while the expression of Ki67 in solid slices was almost negative in both groups. Transfected cells presented slower growth than non-transfected cells in the early stage (2 weeks) and 2 weeks later there was no obvious difference in size(P > 0.05). FCM value accorded well with the result.
CONCLUSION: Introduction of nm23-h1 into the ACC-M cell lines may have transient inhibitory effects on its proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15190789

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  1 in total

1.  Cellular profile of the peritumoral inflammatory infiltrate in squamous cells carcinoma of oral mucosa: Correlation with the expression of Ki67 and histologic grading.

Authors:  Fabricio L D Vieira; Beatriz J Vieira; Marco A M Guimaraes; Fernando M Aarestrup
Journal:  BMC Oral Health       Date:  2008-09-02       Impact factor: 2.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.